The Convertible Note Discount Rate I See Founders Negotiate Wrong Every Time

The Number Everyone Argues About Is Rarely the One That Matters

Founders spend hours negotiating the convertible note discount rate. They push from 25% down to 20%. They feel like they won something.

Then they raise their Series A, watch the cap table update, and realize they gave away far more equity than they planned. Not because of the discount rate. Because of the valuation cap.

The discount rate gets all the attention. The cap drives the outcome.

You need to understand both if you are raising on a convertible note right now. The discount affects every scenario. The cap affects the high-growth scenario. And most early-stage companies hope they are in the high-growth scenario.

Here is how the math works, what the market data says, and where founders consistently leave equity on the table.

What the Convertible Note Discount Rate Does

A convertible note discount rate is a percentage reduction on the price per share that early investors pay when the note converts to equity during a future funding round.

The mechanism is simple. If your Series A prices shares at $2.00 and an investor holds a note with a 20% discount, they convert at $1.60 per share. That $0.40 difference is the reward for investing early when the risk was higher.

The formula is straightforward.

Conversion Price = Next Round Price Per Share x (1 - Discount Rate)

A 20% discount on a $2.00 share price gives a $1.60 conversion price. A 25% discount gives $1.50. The higher the discount, the more shares the early investor gets for the same dollar amount invested.

That is good for investors. Every extra share issued to a note holder comes from your ownership pool.

Applied to a round: if you raise a Series A at a $30 million pre-money valuation and an investor holds a 20% discount, they convert as if the company is worth $24 million. That is a meaningful difference in how many shares they receive compared to Series A investors paying full price.

What the Market Data Shows

Multiple sources put the standard convertible note discount rate in a fairly tight band.

FundersClub puts it directly: discounts range from 0% to as high as 35%, with 20% being common. Westaway, which represents founders in these negotiations, says the discount usually ranges from 15% to 25%, with 20% being by far the norm. DLA Piper puts the negotiable range at 5% to 30%, depending on company stage, risk level, investor relationship, and how long until the anticipated equity round.

Equidam analyzed 552 convertible note transactions through their calculator tool and found an average discount rate of 32.59%. That figure is notably higher than the 20% norm cited by practitioners. The likely explanation is selection bias. Founders stress-testing terms tend to be exploring higher-risk structures or are earlier stage than typical Silicon Valley seed rounds.

Rockies Venture Club has a pointed take on what discount rates signal: founders who offer 25% or 30% to sweeten the deal risk causing Series A investors to balk and demand a reset. Founders who offer 10% or 15% signal that they expect to underperform.

The takeaway is this. In every U.S. seed-stage deal I've seen, 20% is the default starting point. Go above 25% only if you have a specific reason tied to your risk profile or timeline. Go below 15% only if you have traction, competing term sheets, or strong investor demand.

How the Discount and the Cap Interact

In nearly every convertible note I've reviewed, both a valuation cap and a discount rate show up together. When it comes time to convert, the investor gets whichever mechanism produces the lower conversion price. That means the better deal for them.

Here is a concrete example. You take a $500,000 convertible note with a 20% discount and a $15 million valuation cap. Your Series A is priced at a $35 million pre-money valuation, with shares at $2.00 each.

Under the discount: 20% off $2.00 = $1.60 per share.

Under the cap: The $15 million cap against a $35 million round valuation produces a per-share conversion price well below $1.60. The cap wins by a wide margin.

The investor gets far more shares via the cap than the discount alone would have given them. This is exactly why experienced founders treat the discount as a secondary term and fight hardest on the cap.

The math supports this clearly. The discount only dominates when the company's next-round valuation is modest, roughly less than 1.25 times the valuation cap. If the company has grown significantly since the note was issued, the cap produces a better outcome for the investor almost every time. A discount rate can be more predictable, but it does not provide as much protection as a valuation cap in high-growth scenarios.

What this means practically: if you expect a strong Series A, negotiate the valuation cap aggressively. If you anticipate a modest valuation jump, focus on minimizing the discount rate. Both terms are on the table. Treat them as a package, not independent variables.

The Interest Rate Is the Third Term Founders Forget

In my experience reviewing early-stage financings, convertible notes almost always accrue simple interest between 5% and 8% per year, with 5% to 6% being most common. Carta data on pre-seed convertible notes shows the median interest rate held at 7% in Q1, down from a high of 8%, tracking federal rate movements.

The interest does not get paid in cash. It accrues and converts into equity along with the principal at the next financing round. That sounds minor. It is not.

Consider a documented pattern from legal practice: a founder took three separate convertible notes over 18 months totaling $450,000. By the time they raised a Series A, aggregate accrued interest had grown the principal to approximately $480,000. That extra $30,000 in equity being issued was not in the original projections. It showed up on the cap table as founder dilution no one had planned for.

On a $500,000 convertible note at 5% interest over 24 months, founders accrue roughly $50,000 in additional obligations that convert to equity. That is approximately 10% more dilution beyond the principal amount, just from interest accrual.

Founders who projected 15% dilution at Series A discovered it was 18% because they did not account for interest on multiple convertible notes. This is a pattern, not an outlier.

The practical rule: when modeling your fully diluted cap table, account for all accrued interest on all outstanding convertible notes. Run this math before you sign, not after you close your Series A.

What Stage You Are At Changes What Rate Is Fair

Discount rates are not one-size-fits-all. The appropriate range shifts based on where you are and what you are offering investors.

Early-stage companies with just an idea and no traction typically see 20% to 25%. Those with proven traction and revenue signals can justify 10% to 15%. Friends and family rounds sometimes see lower discounts, with competitive seed rounds from professional investors usually settling around the 20% standard.

Higher-risk investments call for larger discounts. Lower-risk investments command lower discounts, and the discount itself is compensation for early risk. The longer the note is expected to be outstanding before conversion, and the less proven the company, the higher the discount an investor will expect.

Stage also affects the cap. Early-stage notes often have caps in the $5 million to $15 million range. Later-stage convertible notes might have higher caps and lower discounts. On the interest rate side, geography matters. Startups in coastal U.S. markets or startup-friendly international hubs tend to secure lower rates due to investor familiarity and competition among lenders.

The Market Has Moved to SAFEs and What That Means for Notes

Convertible notes are still in use, but SAFEs now make up 90% of pre-seed rounds. Carta data shows SAFEs made up a record 90% of all pre-seed rounds in Q1, while convertible notes accounted for 10%. Post-money SAFEs with a valuation cap only and no discount have become the dominant structure, used in 61% of SAFEs.

This context matters for founders still using convertible notes. You are working with a structure that is increasingly the exception at the pre-seed stage. The industries where convertible notes still dominate are energy, biotech and pharma, and medical devices. These are sectors where investors are more accustomed to debt-structured instruments and where the legal treatment of SAFEs is less settled.

YC standardized the SAFE in 2013 and the ecosystem built around it. SAFEs are debt-free instruments. They do not accrue interest, carry no maturity date, and create no repayment obligation if the next round does not happen on schedule. That removes a significant source of founder stress and legal complexity.

Convertible notes still make sense in specific situations. When investors specifically want debt protections. When raising in jurisdictions where SAFEs have unclear legal treatment. In bridge rounds where the conversion timeline is short, three to six months out from a known equity round.

If you are raising a convertible note because your investor wants one, that is a legitimate reason. If you are raising one out of habit, it is worth asking whether a SAFE would serve you better.

The Hidden Risk of Stacking Multiple Notes

Many founders take one note, then another, then another, without fully modeling the cumulative dilution impact. Each note may carry a different cap, a different interest rate, and the maturity dates often vary as well. When they all convert at Series A, the cap table can look very different from what anyone expected.

One documented pattern: a founder takes a $100,000 note with a $5 million cap, then a $100,000 note with a $6 million cap, then a $100,000 note with a $5.5 million cap. By Series A, there is $300,000 or more in principal plus accrued interest converting at different terms. Series A investors sometimes push back on messy pre-money convertible structures before they will close.

The combination of discount rates, valuation caps, and accrued interest across multiple notes can result in unexpected dilution levels that no single note would have produced on its own.

MFN provisions add another layer. If some notes have Most Favored Nation clauses and others do not, one investor can demand term adjustments when they see you gave a later investor a better cap. Standardize your note terms. Consistent caps, discounts, interest rates, and MFN provisions across all notes is worth the effort upfront.

The fix requires discipline: model your cap table before signing any note. Run multiple scenarios. What does conversion look like if your Series A is at $10 million? At $20 million? Model it at $50 million too. Know exactly what you are committing to before you sign, not after.

Maturity Dates Are Not Formalities

A convertible note typically matures in 18 to 24 months. That can look like plenty of runway when you sign. It often is not.

If a note has not converted by the maturity date and no qualified financing has occurred, the company technically owes the principal plus accrued interest back to the investor in cash. I have watched early-stage founders go pale when they do the math on what that number actually looks like in their bank account. That leads to tense negotiations, extensions, and sometimes forced conversions at terms you did not originally agree to.

Investors rarely force repayment because doing so would likely kill the company they invested in. But the maturity date gives investors a tool. Savvy investors use it to negotiate additional terms at extension, often requesting a lower cap or higher discount as the price of buying more time.

If you believe you will raise a Series A in 18 months but you take a note with an 18-month maturity, you have eliminated your margin for error. Build in buffer. Push for 24 months minimum. And if you are taking multiple notes at different times, align their maturity dates so you are not managing multiple extension negotiations simultaneously.

How to Negotiate Your Discount Rate

The discount rate is negotiable, but it is not where experienced founders spend most of their leverage. Here is the priority order that makes sense.

Fight hardest on the valuation cap. The cap determines how much dilution you take if your company performs well. A slightly higher interest rate or longer maturity is an acceptable trade for a higher cap. A lower cap affects every upside scenario you are working toward.

Use 20% as your anchor on the discount. It is the market standard. Investors asking for more than 20% should justify it with the specific risk they are taking. Pre-revenue with no traction, 20% to 25% is reasonable. With traction, push toward 15%.

Use the discount as a trade-off tool. If an investor pushes for a lower valuation cap, consider offering a slightly higher discount as compensation. If they push for a higher discount, push back on the cap. The two terms are connected. Treat them as a package, not independent variables.

Scope MFN clauses narrowly. If MFN provisions are requested, negotiate for clauses that apply only to notes raised within a specific time window. 90 days is a reasonable ask. Or limit the clause to certain terms like the cap but not the discount. This preserves flexibility for later raises.

Align maturity dates across all notes. If you are taking multiple notes at different times, push hard to have the same maturity date for all of them. Staggered maturities create overlapping pressure at the worst possible moment in your fundraising cycle.

One thing worth understanding: the discount rate you agree to today signals something to every future investor who looks at your cap table. A steep discount on early notes suggests early capital was expensive to attract. It is not a disqualifying signal, but it is a data point. The right discount is the lowest number a serious investor will accept given your current position, not the highest one you can offer while still feeling like you got a deal.

A Real-World Example of How Cap vs. Discount Plays Out

Here is the math with round numbers.

You raise $100,000 on a convertible note with a 20% discount rate, a $5 million valuation cap, 5% annual interest, and a 24-month maturity. By conversion, your principal has grown to approximately $110,250 with accrued interest.

Scenario A - Modest growth: Your Series A is at a $6 million pre-money valuation, shares priced at $1.00 each.

Discount route: 20% off $1.00 = $0.80 per share. $110,250 at $0.80 = roughly 138,000 shares.

Cap route: $5 million cap versus $6 million round. The discount produces a lower price here, so the discount applies. Roughly 138,000 shares either way.

Scenario B - Strong growth: Your Series A is at a $20 million pre-money valuation, shares at $1.00 each.

Discount route: 20% off $1.00 = $0.80 per share. $110,250 at $0.80 = roughly 138,000 shares.

Cap route: $5 million cap against a $20 million valuation. The investor converts as if the company is worth $5 million, producing a conversion price around $0.25 per share. $110,250 at $0.25 = roughly 441,000 shares.

In Scenario B, the cap gives the investor more than three times the shares compared to the discount alone. The cap is where early investors get extraordinarily well-compensated in high-growth outcomes. It is also where founders who did not model the cap carefully face the most dilution.

The Counterintuitive Truth About High Discount Rates

There is a dynamic worth understanding when founders offer steep discounts to attract investors faster.

Consider what happens with pricing in any business. One operator who has built and sold businesses observed this pattern directly: the customers who demanded the biggest discounts had the highest churn rate, essentially 100%. Full-price customers left too, eventually. Giving a discount did not just reduce revenue on month one. It eliminated that customer's entire lifetime value. The discount attracted exactly the kind of buyer who would not stick around.

In fundraising, a convertible note discount rate that is too high sends a similar signal. It tells the next investor who looks at your cap table that early capital came at a premium price because your leverage was low. That is useful information for them, and not in your favor.

Founders who offer 10% or 15% send a message that they expect modest performance. Founders who offer 25% or 30% to close faster risk Series A investors demanding a reset on the entire note structure. Neither extreme serves you well.

Start with the lowest number a serious investor will accept. Work up from there based on your traction and timeline. Market conditions set the ceiling.

Where This Fits in the Broader Market Right Now

Carta data across more than 110,000 convertible instruments shows valuation caps trending upward for both SAFEs and convertible notes at most round sizes. Carta researchers attribute this to investors foreseeing higher upside for early-stage startups, driven in part by AI-driven productivity gains that let small teams build faster than before.

The median seed valuation on Carta is $20 million post-money. The median founding team owns 56.2% after a priced seed round, dropping to 36.1% at Series A and 23.0% at Series B. Founders are giving up roughly 20 percentage points per round in early stages. The terms on your convertible note feed directly into those numbers at the first priced round.

Understanding the full structure, cap, interest, maturity, MFN provisions, and the stacking effect across multiple notes, determines whether you reach Series A with the cap table you intended.

Should You Use a Convertible Note at All?

When I talk to pre-seed founders raising in the U.S. from angels or early-stage funds, they almost always end up on a SAFE - it's the simpler structure. No interest accrual, no maturity date, no repayment risk, and significantly less structural complexity. 90% of pre-seed rounds now use SAFEs. There are fewer moving parts that can catch you off guard.

Convertible notes make more sense when your investors specifically want debt protections, when you are doing a true bridge round with a clear equity raise within three to six months, or when operating in a jurisdiction where SAFEs have unclear legal standing. Convertible notes remain the norm in many European markets where the legal framework for debt instruments is better established.

If you use a convertible note, the key is understanding all four terms: discount, cap, interest rate, and maturity. Run your cap table scenarios before you sign. Standardize terms across multiple notes. And build in more maturity runway than your most optimistic fundraising timeline suggests you need.

If reaching the right investors is your current bottleneck, Try ScraperCity free - it lets you search millions of investor and founder contacts by title, geography, industry, and company size so you can build your outreach list before you need it.

The Short Version

The convertible note discount rate is typically 20%. That is where negotiations start and usually end.

But the discount rate alone does not determine how much equity you give up. The valuation cap does more work than the discount in most growth scenarios. Silent dilution accumulates through the interest rate over the life of the note. Multiple notes with different terms stack in ways founders routinely underestimate.

Know all four numbers before you sign anything. Model how they interact. The headline discount rate is a negotiation. The full package is your future cap table.